15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Phase separation of 53BP1 determines liquid‐like behavior of DNA repair compartments

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The DNA damage response ( DDR) generates transient repair compartments to concentrate repair proteins and activate signaling factors. The physicochemical properties of these spatially confined compartments and their function remain poorly understood. Here, we establish, based on live cell microscopy and CRISPR/Cas9‐mediated endogenous protein tagging, that 53 BP1‐marked repair compartments are dynamic, show droplet‐like behavior, and undergo frequent fusion and fission events. 53 BP1 assembly, but not the upstream accumulation of γH2 AX and MDC1, is highly sensitive to changes in osmotic pressure, temperature, salt concentration and to disruption of hydrophobic interactions. Phase separation of 53 BP1 is substantiated by optoDroplet experiments, which further allowed dissection of the 53 BP1 sequence elements that cooperate for light‐induced clustering. Moreover, we found the tumor suppressor protein p53 to be enriched within 53 BP1 optoDroplets, and conditions that disrupt 53 BP1 phase separation impair 53 BP1‐dependent induction of p53 and diminish p53 target gene expression. We thus suggest that 53 BP1 phase separation integrates localized DNA damage recognition and repair factor assembly with global p53‐dependent gene activation and cell fate decisions.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          ATR prohibits replication catastrophe by preventing global exhaustion of RPA.

          ATR, activated by replication stress, protects replication forks locally and suppresses origin firing globally. Here, we show that these functions of ATR are mechanistically coupled. Although initially stable, stalled forks in ATR-deficient cells undergo nucleus-wide breakage after unscheduled origin firing generates an excess of single-stranded DNA that exhausts the nuclear pool of RPA. Partial reduction of RPA accelerated fork breakage, and forced elevation of RPA was sufficient to delay such "replication catastrophe" even in the absence of ATR activity. Conversely, unscheduled origin firing induced breakage of stalled forks even in cells with active ATR. Thus, ATR-mediated suppression of dormant origins shields active forks against irreversible breakage via preventing exhaustion of nuclear RPA. This study elucidates how replicating genomes avoid destabilizing DNA damage. Because cancer cells commonly feature intrinsically high replication stress, this study also provides a molecular rationale for their hypersensitivity to ATR inhibitors. Copyright © 2013 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress.

            Completion of genome duplication is challenged by structural and topological barriers that impede progression of replication forks. Although this can seriously undermine genome integrity, the fate of DNA with unresolved replication intermediates is not known. Here, we show that mild replication stress increases the frequency of chromosomal lesions that are transmitted to daughter cells. Throughout G1, these lesions are sequestered in nuclear compartments marked by p53-binding protein 1 (53BP1) and other chromatin-associated genome caretakers. We show that the number of such 53BP1 nuclear bodies increases after genetic ablation of BLM, a DNA helicase associated with dissolution of entangled DNA. Conversely, 53BP1 nuclear bodies are partially suppressed by knocking down SMC2, a condensin subunit required for mechanical stability of mitotic chromosomes. Finally, we provide evidence that 53BP1 nuclear bodies shield chromosomal fragile sites sequestered in these compartments against erosion. Together, these data indicate that restoration of DNA or chromatin integrity at loci prone to replication problems requires mitotic transmission to the next cell generations. © 2011 Macmillan Publishers Limited. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Acetylation Limits 53BP1 Association with Damaged Chromatin to Promote Homologous Recombination

              The pathogenic sequelae of BRCA1 mutation in human and mouse cells are mitigated by concomitant deletion of 53BP1, which binds histone H4 dimethylated at Lys20 (H4K20me2) to promote nonhomologous end-joining, suggesting a balance between BRCA1 and 53BP1 regulates DNA double-strand break (DSB) repair mechanism choice. Here, we document that acetylation is a key determinant of this balance. TIP60 acetyltransferase deficiency reduced BRCA1 at DSB chromatin with commensurate increases in 53BP1, while HDAC inhibition yielded the opposite effect. TIP60 -dependent H4 acetylation diminished 53BP1 binding to H4K20me2 in part through disruption of a salt bridge between H4K16 and Glu1551 in the 53BP1 Tudor domain. Moreover, TIP60 deficiency impaired HR and conferred sensitivity to PARP inhibition in a 53BP1-dependent manner. These findings demonstrate that acetylation in cis to H4K20me2 regulates relative BRCA1 and 53BP1 DSB chromatin occupancy to direct DNA repair mechanism.
                Bookmark

                Author and article information

                Contributors
                matthias.altmeyer@uzh.ch
                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                01 July 2019
                15 August 2019
                01 July 2019
                : 38
                : 16 ( doiID: 10.1002/embj.v38.16 )
                : e101379
                Affiliations
                [ 1 ] Department of Molecular Mechanisms of Disease University of Zurich Zurich Switzerland
                [ 2 ] Cancer Biology PhD Program Life Science Zurich Graduate School Zurich Switzerland
                [ 3 ]Present address: Institute of Biochemistry ETH Zurich Zurich Switzerland
                Author notes
                [*] [* ]Corresponding author. Tel: + 41 44 63 55 491; E‐mail: matthias.altmeyer@ 123456uzh.ch
                Author information
                https://orcid.org/0000-0001-5009-8884
                https://orcid.org/0000-0003-3780-1170
                Article
                EMBJ2018101379
                10.15252/embj.2018101379
                6694294
                31267591
                ecee8e34-7da2-4efc-bd2b-15b56debd113
                © 2019 The Authors. Published under the terms of the CC BY NC ND 4.0 license

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 14 December 2018
                : 08 May 2019
                : 28 May 2019
                Page count
                Figures: 12, Tables: 0, Pages: 17, Words: 12412
                Funding
                Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
                Award ID: 150690
                Award ID: 179057
                Funded by: EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC)
                Award ID: 714326
                Funded by: Novartis Stiftung für Medizinisch‐BiologischeForschung (Novartis Foundation for Medical‐Biological Research)
                Award ID: 16B078
                Funded by: Krebsliga Schweiz (Swiss Cancer League)
                Award ID: KFS‐4406‐02‐2018
                Categories
                Article
                Articles
                Custom metadata
                2.0
                embj2018101379
                15 August 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.7 mode:remove_FC converted:15.08.2019

                Molecular biology
                53bp1,dna damage response,genome stability,liquid–liquid phase separation,p53,chromatin, epigenetics, genomics & functional genomics,dna replication, repair & recombination

                Comments

                Comment on this article